Clevergene Biocorp Private Limited

Clevergene Biocorp Private Limited - life sciences in Bengaluru, Karnataka, India. FY 2026 financials & compliance.
CIN U73200KA2013PTC069488 Incorporated 04 June 2013 ROC Bangalore HQ Bengaluru, Karnataka, India
Active Private Limited Company life sciences MSME · Small
Data last updated
Revenue · FY 2022
₹9.97 Cr
▲ 39% YoY
Net loss · FY 2022
₹1.74 Cr
Net margin -17.4%
EBITDA · FY 2022
₹1.14 Cr
EBITDA margin 11.5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2.72 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Employees · EPFO
2
Provident fund records
Directors on board
3
As per MCA filings

About Clevergene Biocorp Private Limited

Data last updated:

Clevergene Biocorp Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 04 June 2013 and has been in existence for over 13 years.

The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73200KA2013PTC069488. Its GSTIN is 29AAFCC2778K1Z5 (Karnataka).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2.72 Lakh. It is led by directors including Antony Thomas and Tony Jose.

Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Ground Floor & 1st Floor Site No. 617 5th Main Ombr Layout Banaswadi, Bengaluru, Karnataka, India – 560043.

As per the financials filed for FY 2022, the company reported a revenue of ₹9.97 Cr, a growth of 39% compared to the previous year. For the same year it recorded a net loss of ₹1.74 Cr (net margin -17.4%) and EBITDA of ₹1.14 Cr (EBITDA margin 11.5%). Revenue has grown at a compounded annual rate (CAGR) of 60% over three years and 108% over five years.

The company has about 2 employees on its provident fund (EPFO) records.

The company is associated with 2 brands: The Gene Lab and Clevergene. Court records list 32 cases involving the company, including 2 filed by the company and 30 filed against it; 16 cases are pending. The company has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.09 Cr; the latest was in February 2022. The company has 4 MSME Form 1 returns on record between 2019 and 2022, listing 32 overdue payments to 8 micro and small suppliers.

Clevergene Biocorp Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KR-03-0040590). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website clevergene.in.

Company details

CIN U73200KA2013PTC069488
Registration Number 069488
Incorporation Date 04 June 2013
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KR-03-0040590

Recognitions & Rankings of Clevergene Biocorp

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-KR-03-0040590

Contact details

Clevergene Biocorp Private Limited's registered office is in Bengaluru, Karnataka. Its website is clevergene.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Ground Floor & 1st Floor Site No. 617 5th Main Ombr Layout Banaswadi, Bengaluru, Karnataka, India – 560043
  • Industry
    Life Sciences, Biotechnology

To see the full contact details of Clevergene Biocorp Private Limited, buy the company report.

Comprehensive company report
Clevergene Biocorp Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Clevergene Biocorp operates two associated brands: The Gene Lab and Clevergene. Each brand links to its own profile.

BrandDescriptionWebsite
Provider of RT-PCR testing servicesthegenelab.com
Genomic-based bioinformatics solutions are provided for research and translational sciences.clevergene.in

Business activity

The main business activity of Clevergene Biocorp is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
MProfessional, Scientific and TechnicalM9Other professional, scientific and technical activities

To see the full business activity and turnover split of Clevergene Biocorp Private Limited, buy the company report.

Financials of Clevergene Biocorp Private Limited

FY 2022 filings available

Clevergene Biocorp Private Limited reported revenue of ₹9.97 Cr (up 39% YoY) for FY 2022.

Revenue · FY 2022
₹9.97 Cr ▲ 39%
Net loss · FY 2022
₹1.74 Cr margin -17.4%
EBITDA · FY 2022
₹1.14 Cr margin 11.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 39%
3 years · compounded
▲ 60%
5 years · compounded
▲ 108%
EBITDA CAGR growth
1 year
▼ 7%
3 years · compounded
▲ 27%
5 years · compounded
▲ 45%

Revenue has grown at a compounded annual rate (CAGR) of 108% over five years, including 39% growth in the latest year. EBITDA fell 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹9.97 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.14 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.74 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20FY 2018-19FY 2017-18
Profitability
EBITDA Margin11.5%
Net Profit Margin-17.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Clevergene Biocorp Private Limited, buy the company report.

Board of directors of Clevergene Biocorp Private Limited

Clevergene Biocorp has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Antony ThomasDirector16 May 201610 Years 5 MonthsCurrent
Tony JoseDirector04 Jun 201313 Years 4 MonthsCurrent
Ria DuttaDirector10 Nov 20250 Years 11 MonthsCurrent

Auditor

Clevergene Biocorp Private Limited is audited by L.K. Kejriwal & Co for the financial year 2022.

Auditor firmFinancial yearFirm registration number
L.K. Kejriwal & CoFY 2022001368C

Shareholding

The shareholding of Clevergene Biocorp Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Clevergene Biocorp Private Limited, buy the company report.

Deals & funding

Clevergene Biocorp Private Limited has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.09 Cr; the latest was in February 2022.

Total deals
4
Funding rounds
2
Secondary share transfers
2
Disclosed funding
₹7.09 Cr

Deals on record (3 of 4)

WhenDealAmountParties
Jan 2022Secondary share transferUndisclosedSeller: an individual
Jan 2020Funding round₹4.49 CrInvestors: Auxano, an individual
Jun 2018Secondary share transferUndisclosedBuyer: 2 individuals
Seller: 2 individuals

To see the full deal history of Clevergene Biocorp Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Clevergene Biocorp Private Limited has 4 MSME Form 1 returns on record between 2019 and 2022, listing 32 overdue payments to 8 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 8)

SupplierAmount dueDue sinceReported on
Aic Enterprises Private Limited
Medisave Health and Lifestyle Private Limited
Bionova Supplies
Criticalog India Private Limited
an individual supplier

To see the full MSME payment records of Clevergene Biocorp Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Clevergene Biocorp Private Limited has a workforce of 2 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.

Employee count
2
Active EPFO establishments
1
Employee growth
-95.45%

GST

Clevergene Biocorp has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
29AAFCC2778K1Z5KarnatakaActive01 Jul 2017

To see the full GST registrations and return filing status of Clevergene Biocorp Private Limited, buy the company report.

Recent activity

Clevergene Biocorp Private Limited has 6 board changes on record since 2013: 3 appointments and 3 cessations. The latest: Ria Dutta was appointed as Director on 10 Nov 2025.

Appointed
Ria Dutta was appointed as Director.
AGM
Clevergene Biocorp Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Filing
Clevergene Biocorp Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Bangalore.
Ceased
Rajasekhara Reddy Ravuri ceased to be Additional Director.
Ceased
Dhruv Prasher ceased to be Director.
Ceased
Antony Thomas ceased to be Additional Director.
Appointed
Antony Thomas was appointed as Director.
Appointed
Tony Jose was appointed as Director.
Incorporation
04 Jun 2013
Clevergene Biocorp Private Limited was registered on 04 Jun 2013 with Roc Bangalore & aged 13 years 4 months as per MCA records.

Frequently asked questions

Clevergene Biocorp is an active private limited company based in Bengaluru, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 04 June 2013 (13+ years old) and is registered under CIN U73200KA2013PTC069488.

Clevergene Biocorp has 3 current directors:

The latest financial statements of Clevergene Biocorp on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.

The GSTIN of Clevergene Biocorp is 29AAFCC2778K1Z5, registered in Karnataka.

The CIN (Corporate Identification Number) of Clevergene Biocorp is U73200KA2013PTC069488. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Clevergene Biocorp has 32 court cases on record: 2 filed by the company and 30 filed against it. 16 are pending. Most are in the district courts.

Clevergene Biocorp was incorporated on 04 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Bangalore.

Clevergene Biocorp has 4 deals on record (2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.09 Cr; the latest was in February 2022.

Ria Dutta was appointed as Director on 10 Nov 2025. Rajasekhara Reddy Ravuri ceased to be Additional Director on 15 Oct 2021. Dhruv Prasher ceased to be Director on 30 Sep 2021. Clevergene Biocorp has 6 board changes on record in total.

Yes, Clevergene Biocorp is registered as a small enterprise under Udyam registration (number: UDYAM-KR-03-0040590).

Clevergene Biocorp has 4 MSME Form 1 returns on record between 2019 and 2022, listing 32 overdue payments to 8 micro and small suppliers. The latest return was filed on 01 Jun 2022.